SynthesisGastroenterology2012

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

Jesper B Andersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.